{
  "retracted": false,
  "timestamp": 1542672000000,
  "updates": [
    {
      "timestamp": 1574817705491,
      "identifier": {
        "doi": "10.1212/wnl.0000000000005461"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/wnl.0000000000005255"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy"
}
